These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 20858686

  • 1. Basal and insulin mediated VLDL-triglyceride kinetics in type 2 diabetic men.
    Sørensen LP, Andersen IR, Søndergaard E, Gormsen LC, Schmitz O, Christiansen JS, Nielsen S.
    Diabetes; 2011 Jan; 60(1):88-96. PubMed ID: 20858686
    [Abstract] [Full Text] [Related]

  • 2. Postprandial VLDL-TG metabolism in type 2 diabetes.
    Søndergaard E, Johansen RF, Jensen MD, Nielsen S.
    Metabolism; 2017 Oct; 75():25-35. PubMed ID: 28964326
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Impact of body composition on very-low-density lipoprotein-triglycerides kinetics.
    Gormsen LC, Nellemann B, Sørensen LP, Jensen MD, Christiansen JS, Nielsen S.
    Am J Physiol Endocrinol Metab; 2009 Jan; 296(1):E165-73. PubMed ID: 18984851
    [Abstract] [Full Text] [Related]

  • 5. Impaired Insulin Suppression of VLDL-Triglyceride Kinetics in Nonalcoholic Fatty Liver Disease.
    Poulsen MK, Nellemann B, Stødkilde-Jørgensen H, Pedersen SB, Grønbæk H, Nielsen S.
    J Clin Endocrinol Metab; 2016 Apr; 101(4):1637-46. PubMed ID: 26829441
    [Abstract] [Full Text] [Related]

  • 6. Pathophysiology of Diabetic Dyslipidemia.
    Hirano T.
    J Atheroscler Thromb; 2018 Sep 01; 25(9):771-782. PubMed ID: 29998913
    [Abstract] [Full Text] [Related]

  • 7. Increased VLDL-TG Fatty Acid Storage in Skeletal Muscle in Men With Type 2 Diabetes.
    Andersen IR, Søndergaard E, Sørensen LP, Nellemann B, Gormsen LC, Jensen MD, Nielsen S.
    J Clin Endocrinol Metab; 2017 Mar 01; 102(3):831-839. PubMed ID: 27898284
    [Abstract] [Full Text] [Related]

  • 8. No effect of resveratrol on VLDL-TG kinetics and insulin sensitivity in obese men with nonalcoholic fatty liver disease.
    Poulsen MK, Nellemann B, Bibby BM, Stødkilde-Jørgensen H, Pedersen SB, Grønbaek H, Nielsen S.
    Diabetes Obes Metab; 2018 Oct 01; 20(10):2504-2509. PubMed ID: 29885082
    [Abstract] [Full Text] [Related]

  • 9. One day of mixed meal overfeeding reduces hepatic insulin sensitivity and increases VLDL particle but not VLDL-triglyceride secretion in overweight and obese men.
    Smith GI, Magkos F, Reeds DN, Okunade AL, Patterson BW, Mittendorfer B.
    J Clin Endocrinol Metab; 2013 Aug 01; 98(8):3454-62. PubMed ID: 23750033
    [Abstract] [Full Text] [Related]

  • 10. Similar insulin regulation of splanchnic FFA and VLDL-TG in men with nonalcoholic hepatic steatosis and steatohepatitis.
    Risikesan J, Heebøll S, Kumarathas I, Søndergaard E, Johansen RF, Ringgaard S, Aagaard NK, Sandahl TD, Villadsen GE, Gormsen LC, Frystyk J, Jensen MD, Grønbæk H, Nielsen S.
    J Lipid Res; 2024 Jul 01; 65(7):100580. PubMed ID: 38901559
    [Abstract] [Full Text] [Related]

  • 11. Gender differences in VLDL1 and VLDL2 triglyceride kinetics and fatty acid kinetics in obese postmenopausal women and obese men.
    Sarac I, Backhouse K, Shojaee-Moradie F, Stolinski M, Robertson MD, Bell JD, Thomas EL, Hovorka R, Wright J, Umpleby AM.
    J Clin Endocrinol Metab; 2012 Jul 01; 97(7):2475-81. PubMed ID: 22508714
    [Abstract] [Full Text] [Related]

  • 12. Lean body mass, not FFA, predicts VLDL-TG secretion rate in healthy men.
    Søndergaard E, Nellemann B, Sørensen LP, Christensen B, Gormsen LC, Nielsen S.
    Obesity (Silver Spring); 2015 Jul 01; 23(7):1379-85. PubMed ID: 26052691
    [Abstract] [Full Text] [Related]

  • 13. The contribution of splanchnic fat to VLDL triglyceride is greater in insulin-resistant than insulin-sensitive men and women: studies in the postprandial state.
    Hodson L, Bickerton AS, McQuaid SE, Roberts R, Karpe F, Frayn KN, Fielding BA.
    Diabetes; 2007 Oct 01; 56(10):2433-41. PubMed ID: 17601988
    [Abstract] [Full Text] [Related]

  • 14. Effects of insulin on cholesterol synthesis in type II diabetes patients.
    Scoppola A, Testa G, Frontoni S, Maddaloni E, Gambardella S, Menzinger G, Lala A.
    Diabetes Care; 1995 Oct 01; 18(10):1362-9. PubMed ID: 8721938
    [Abstract] [Full Text] [Related]

  • 15. Attenuated suppression of lipolysis explains the increases in triglyceride secretion and concentration associated with basal insulin peglispro relative to insulin glargine treatment in patients with type 1 diabetes.
    Johansen RF, Søndergaard E, Linnebjerg H, Garhyan P, Lam ECQ, Porksen N, Jacober SJ, Nielsen S.
    Diabetes Obes Metab; 2018 Feb 01; 20(2):419-426. PubMed ID: 28817248
    [Abstract] [Full Text] [Related]

  • 16. Isolated hyperglycaemia does not increase VLDL-triacylglycerol secretion in type 1 diabetic men.
    Johansen RF, Søndergaard E, Sørensen LP, Nellemann B, Christiansen JS, Nielsen S.
    Diabetologia; 2015 Feb 01; 58(2):355-62. PubMed ID: 25385409
    [Abstract] [Full Text] [Related]

  • 17. Effect of fenofibrate and niacin on intrahepatic triglyceride content, very low-density lipoprotein kinetics, and insulin action in obese subjects with nonalcoholic fatty liver disease.
    Fabbrini E, Mohammed BS, Korenblat KM, Magkos F, McCrea J, Patterson BW, Klein S.
    J Clin Endocrinol Metab; 2010 Jun 01; 95(6):2727-35. PubMed ID: 20371660
    [Abstract] [Full Text] [Related]

  • 18. Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM.
    Cummings MH, Watts GF, Umpleby AM, Hennessy TR, Naoumova R, Slavin BM, Thompson GR, Sönksen PH.
    Diabetologia; 1995 Aug 01; 38(8):959-67. PubMed ID: 7589883
    [Abstract] [Full Text] [Related]

  • 19. VLDL triglyceride kinetics in Wistar fatty rats, an animal model of NIDDM: effects of dietary fructose alone or in combination with pioglitazone.
    Kazumi T, Hirano T, Odaka H, Ebara T, Amano N, Hozumi T, Ishida Y, Yoshino G.
    Diabetes; 1996 Jun 01; 45(6):806-11. PubMed ID: 8635657
    [Abstract] [Full Text] [Related]

  • 20. Lipoprotein lipase activity does not predict very low-density lipoprotein-triglyceride fatty acid oxidation during exercise.
    Søndergaard E, Andersen IR, Sørensen LP, Gormsen LC, Nielsen S.
    Scand J Med Sci Sports; 2017 May 01; 27(5):474-481. PubMed ID: 28207959
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.